跳至主要内容
临床试验/PACTR201801002743482
PACTR201801002743482尚未招募未知

Comparative long-term effects of depot medroxyprogesterone acetate, a levonorgestrel implant and a copper intrauterine device on depression and sexual dysfunction: An ancillary study of the ECHO* randomised trial

Effective Care Research Unit0 个研究点目标入组 291 人开始时间: 2017年11月2日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
291

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 35 Year(s)(—)
性别
Female

入选标准

  • ¿16 to 35 years of age
  • ¿HIV sero-negative at baseline
  • ¿Seeking effective contraception
  • ¿Able and willing to provide written informed consent
  • ¿Agrees to be randomised to either the copper IUD, DMPA, or LNG implant
  • ¿Agrees to use assigned method for 18 months
  • ¿Agrees to follow all study requirements
  • ¿Intends to stay in the study area for the next 18 months and willing and able to provide adequate locator information
  • ¿If has had a recent third trimester birth, is at least 6 weeks¿ postpartum
  • ¿Is sexually active (has had vaginal sex within the last 3 months) or has been pregnant within the last 3 months
  • ¿Agrees not to participate in studies of drugs or vaccines or any other clinical research study while participating in this study

排除标准

  • Women are not eligible to participate if they have medical contraindications to the IUD, DMPA, or LNG implant (WHO Medical Eligibility Criteria category 3 or 4),

研究者

相似试验